Published in Lancet on November 16, 2002
Ultra-sound for AAA Screening in Smoking Israeli Arab Men | NCT02306304
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
New BMJ policy on economic evaluations. BMJ (2002) 4.27
Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ (2004) 2.70
Editor's Choice - Self-referral to the NHS Abdominal Aortic Aneurysm Screening Programme. Eur J Vasc Endovasc Surg (2016) 2.57
Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg (2012) 2.55
Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ (2005) 2.33
Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair. J Vasc Surg (2009) 2.16
Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol (2010) 2.11
Biomechanics of abdominal aortic aneurysm. J Biomech (2007) 2.02
Estimating the population impact of preventive interventions from randomized trials. Am J Prev Med (2011) 1.72
Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation (2006) 1.72
Medical management of small abdominal aortic aneurysms. Circulation (2008) 1.67
Changes in abdominal aortic aneurysm rupture and short-term mortality, 1995-2008: a retrospective observational study. Ann Surg (2012) 1.56
Long term outcomes in men screened for abdominal aortic aneurysm: prospective cohort study. BMJ (2012) 1.53
Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study. JACC Cardiovasc Imaging (2012) 1.52
Smoking, sex, risk factors and abdominal aortic aneurysms: a prospective study of 18 782 persons aged above 65 years in the Southern Community Cohort Study. J Epidemiol Community Health (2015) 1.46
Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Soc Echocardiogr (2009) 1.45
TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial. Trials (2015) 1.41
The outcome of endovascular repair of small abdominal aortic aneurysms. Ann Surg (2007) 1.39
Daily diurnal variation in admissions for ruptured abdominal aortic aneurysms. World J Surg (2007) 1.39
Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort. Diabetologia (2010) 1.39
Screening men for aortic aneurysm. BMJ (2002) 1.33
Should we screen for abdominal aortic aneurysm? Yes. BMJ (2008) 1.31
Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. JACC Cardiovasc Imaging (2009) 1.30
Screening for abdominal aortic aneurysms in men. BMJ (2004) 1.21
Extracolonic findings at computed tomography colonography are a challenge. Gut (2003) 1.20
Distribution of coronary artery calcium scores by Framingham 10-year risk strata in the MESA (Multi-Ethnic Study of Atherosclerosis) potential implications for coronary risk assessment. J Am Coll Cardiol (2011) 1.15
Fluid structure interaction of patient specific abdominal aortic aneurysms: a comparison with solid stress models. Biomed Eng Online (2006) 1.12
Better safe than sorry? BMJ (2007) 1.12
Psychosocial impact of finding small aneurysms that are left untreated in patients previously operated on for ruptured aneurysms. J Neurol Neurosurg Psychiatry (2006) 1.10
Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact. Circulation (2011) 1.07
Emergency ultrasound of the abdominal aorta by UK emergency physicians: a prospective cohort study. Emerg Med J (2007) 1.05
Aortic dimensions and the risk of dissection. Heart (2006) 1.01
Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediate-sized AAA, and management of symptomatic AAA. Proc (Bayl Univ Med Cent) (2005) 1.00
Optimal selection of patients for elective abdominal aortic aneurysm repair based on life expectancy. J Vasc Surg (2013) 0.99
Molecular imaging of matrix metalloproteinase activation to predict murine aneurysm expansion in vivo. J Nucl Med (2010) 0.99
Abdominal aortic aneurysm screening: how many life years lost from underuse of the medicare screening benefit? J Gen Intern Med (2014) 0.97
Diagnostic and therapeutic strategies for small abdominal aortic aneurysms. Nat Rev Cardiol (2011) 0.97
Hemodynamic influences on abdominal aortic aneurysm disease: Application of biomechanics to aneurysm pathophysiology. Vascul Pharmacol (2010) 0.95
Cost-effectiveness of CT colonography. Radiol Clin North Am (2013) 0.93
Epidemiology, comparative effectiveness research, and the National Institutes of Health: forces for health. Epidemiology (2011) 0.93
Elective surgery for aortic abdominal aneurysm: comparison of English outcomes with those elsewhere. J Epidemiol Community Health (2007) 0.89
CT screening: a trade-off of risks, benefits, and costs. J Clin Invest (2003) 0.89
Screening for abdominal aortic aneurysms in men: a Canadian perspective using Monte Carlo-based estimates. Can J Surg (2008) 0.89
Ultrasound screening for abdominal aortic aneurysm: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.89
The lifetime prevalence of abdominal aortic aneurysms among siblings of aneurysm patients is eightfold higher than among siblings of spouses: an analysis of 187 aneurysm families in Nova Scotia, Canada. J Vasc Surg (2005) 0.88
Office-based ultrasound screening for abdominal aortic aneurysm. Can Fam Physician (2012) 0.87
Health research improves healthcare: now we have the evidence and the chance to help the WHO spread such benefits globally. Health Res Policy Syst (2015) 0.87
Risk stratification by pre-operative cardiopulmonary exercise testing improves outcomes following elective abdominal aortic aneurysm surgery: a cohort study. Perioper Med (Lond) (2013) 0.87
Emotional impact of screening: a systematic review and meta-analysis. BMC Public Health (2011) 0.86
Choosing sensitivity analyses for randomised trials: principles. BMC Med Res Methodol (2014) 0.86
Reference diameters of the abdominal aorta and iliac arteries in the Korean population. Yonsei Med J (2013) 0.86
Prevalence and trends of the abdominal aortic aneurysms epidemic in general population--a meta-analysis. PLoS One (2013) 0.86
Abdominal aortic aneurysm: A comprehensive review. Exp Clin Cardiol (2011) 0.85
Abdominal aortic aneurysms, or a relatively large diameter of non-aneurysmal aortas, increase total and cardiovascular mortality: the Tromsø study. Int J Epidemiol (2009) 0.85
ACR Appropriateness Criteria® pulsatile abdominal mass, suspected abdominal aortic aneurysm. Int J Cardiovasc Imaging (2012) 0.84
Pathology, natural history and treatment of abdominal aortic aneurysms. Clin Res Cardiol (2006) 0.83
Geography, private costs and uptake of screening for abdominal aortic aneurysm in a remote rural area. BMC Public Health (2006) 0.83
Statin therapy reduces growth of abdominal aortic aneurysms. J Investig Med (2011) 0.83
Imaging of Abdominal Aortic Aneurysm: the present and the future. Curr Vasc Pharmacol (2010) 0.82
National screening programme for aortic aneurysm. BMJ (2004) 0.82
Molecular imaging of aortic aneurysms. Circ Cardiovasc Imaging (2012) 0.81
Open versus endovascular repair of abdominal aortic aneurysm: a survey of Canadian vascular surgeons. Can J Surg (2008) 0.81
Abdominal aortic aneurysm screening during transthoracic echocardiography: Cardiologist and vascular medicine specialist interpretation. World J Cardiol (2012) 0.81
Use of a Web-based clinical decision support system to improve abdominal aortic aneurysm screening in a primary care practice. J Eval Clin Pract (2011) 0.80
Vascular surgery, ICU and HDU: a 14-year observational study. Ann R Coll Surg Engl (2008) 0.80
Recent developments in vascular surgery. BMJ (2003) 0.80
Prevalence of previously undiagnosed abdominal aortic aneurysms in the area of Como: the ComoCuore "looking for AAA" ultrasonography screening. Int J Cardiovasc Imaging (2016) 0.80
Vascular ultrasound screening for asymptomatic abdominal aortic aneurysm. Healthc Policy (2008) 0.79
Epidemiology, Clinical Features, and Prescribing Patterns of Aortic Aneurysm in Asian Population From 2005 to 2011. Medicine (Baltimore) (2015) 0.79
Delayed enhancement on computed tomography in abdominal aortic aneurysm wall. Heart Vessels (2007) 0.79
Ultrasound surveillance of ectatic abdominal aortas. Ann R Coll Surg Engl (2008) 0.79
Age-specific incidence, risk factors and outcome of acute abdominal aortic aneurysms in a defined population. Br J Surg (2015) 0.79
Endovascular aortic aneurysm repair (EVAR). Ulster Med J (2013) 0.79
Ultrasonographic screening for the detection of abdominal aortic aneurysms. Dtsch Arztebl Int (2009) 0.79
Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic Aneurysm. ACS Med Chem Lett (2014) 0.79
Surface curvature as a classifier of abdominal aortic aneurysms: a comparative analysis. Ann Biomed Eng (2012) 0.79
Current trends of major arterial diseases in Korea: based on data from the Health Insurance Review and Assessment Service. Ann Surg Treat Res (2016) 0.78
High Structural Stress and Presence of Intraluminal Thrombus Predict Abdominal Aortic Aneurysm 18F-FDG Uptake: Insights From Biomechanics. Circ Cardiovasc Imaging (2016) 0.78
Genomic research to identify novel pathways in the development of abdominal aortic aneurysm. Cardiol Res Pract (2012) 0.78
Non-invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT): Design of a Phase IIb, placebo-controlled, double-blind, randomized clinical trial of doxycycline for the reduction of growth of small abdominal aortic aneurysm. Contemp Clin Trials (2016) 0.78
Endovascular abdominal aortic aneurysm repair. Postgrad Med J (2007) 0.77
Advances in determining abdominal aortic aneurysm size and growth. World J Radiol (2016) 0.77
Cost-effectiveness of the National Health Service Abdominal Aortic Aneurysm Screening Programme in England. Br J Surg (2014) 0.76
Abdominal aortic aneurysm repair in cardiac high risk patients--medication, surgery or stent? Clin Res Cardiol (2008) 0.75
Vascular disease: is AAA screening worth the cost? Nat Rev Cardiol (2009) 0.75
Morphometric analysis of anatomic variables affecting endovascular stent design in patients undergoing elective and emergency repair of endovascular abdominal aortic aneurysm. Can J Surg (2010) 0.75
Growth of screen-detected abdominal aortic aneurysms in men: a bayesian analysis. CPT Pharmacometrics Syst Pharmacol (2012) 0.75
French women from multiplex abdominal aortic aneurysm families should be screened. Ann Surg (2005) 0.75
Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial. Trials (2017) 0.75
Prevalence of abdominal aortic aneurysms in over 65-year-old men with inguinal hernias. Ann R Coll Surg Engl (2008) 0.75
Low prevalence of abdominal aortic aneurysm in the Seychelles population aged 50 to 65 years. Cardiovasc J Afr (2013) 0.75
Novices may be trained to screen for abdominal aortic aneurysms using ultrasound. Cardiovasc Ultrasound (2013) 0.75
Screening for abdominal aortic aneurysm: screening reduces deaths related to aneurysm. BMJ (2005) 0.75
Screening for abdominal aortic aneurysm: headline is misleading. BMJ (2005) 0.75
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11
Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ (1980) 15.47
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ (1994) 11.85
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet (1984) 10.22
Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess (1998) 9.32
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Detecting and describing heterogeneity in meta-analysis. Stat Med (1998) 8.44
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet (1987) 6.91
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet (1986) 6.51
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 6.48
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol (1987) 6.20
Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet (1984) 5.87
Assessing possible hazards of reducing serum cholesterol. BMJ (1994) 5.61
Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet (2000) 5.61
Will genetics revolutionize medicine? N Engl J Med (2000) 5.41
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health (1989) 5.20
Disease susceptibility genes--their identification by multiple case family studies. Tissue Antigens (1976) 5.17
Inability of trained nurses to perform basic life support. Br Med J (Clin Res Ed) (1987) 5.08
Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med (2000) 4.81
Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol (1978) 4.76
Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics (1984) 4.73
Incidence and aetiology of heart failure; a population-based study. Eur Heart J (1999) 4.56
Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer (1997) 4.47
Monitoring the prevalence of HIV. BMJ (1989) 4.46
Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am (1992) 4.34
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18
Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol (1983) 4.11
Does breathing other people's tobacco smoke cause lung cancer? Br Med J (Clin Res Ed) (1986) 4.06
Cost-benefit analysis of long-term haemodialysis for chronic renal failure. Br Med J (1975) 3.87
Seasonal variation in arterial blood pressure. Br Med J (Clin Res Ed) (1982) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
Breast cancer treatment and natural history: new insights from results of screening. Lancet (1992) 3.77
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ (1998) 3.71
Multistage models and primary prevention of cancer. J Natl Cancer Inst (1980) 3.55
Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst (2004) 3.53
The population genetics of antibiotic resistance. Clin Infect Dis (1997) 3.51
Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun (2008) 3.48
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Modelling in economic evaluation: an unavoidable fact of life. Health Econ (1997) 3.40
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol (2001) 3.35
Dietary effects on breast-cancer risk in Singapore. Lancet (1991) 3.32
A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med (2007) 3.27
Haemostatic function and cardiovascular death: early results of a prospective study. Lancet (1980) 3.25
Variations in GP night visiting rates: medical organisation and consumer demand. Br Med J (1977) 3.24
A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98
Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer (1973) 2.93
The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? Int J Epidemiol (2003) 2.89
Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 2.86
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med (2002) 2.86
The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol (1985) 2.83
CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun (2008) 2.76
Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med (2002) 2.73
Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. Eur J Clin Nutr (2003) 2.68
Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. BMJ (1994) 2.65
Scheduling of revaccination against hepatitis B virus. Lancet (1991) 2.65
Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet (1992) 2.64
Psychological impact of predicting individuals' risks of illness: a systematic review. Soc Sci Med (1999) 2.63
Indirect standardization and multiplicative models for rates, with reference to the age adjustment of cancer incidence and relative frequency data. J Chronic Dis (1975) 2.62
AIDS predictions. Lancet (1993) 2.56
Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg (2012) 2.55
A likelihood approach to meta-analysis with random effects. Stat Med (1996) 2.54
Hospitalization of patients with heart failure: a population-based study. Eur Heart J (2002) 2.54
Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. The British Family Heart Study. Arch Fam Med (1997) 2.41
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer (1999) 2.36
The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol (1984) 2.35
Age at last full-term pregnancy and risk of breast cancer. Lancet (1993) 2.34
A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27
The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy. Pharmacoeconomics (1993) 2.26
Leukemia following Hodgkin's disease. N Engl J Med (1990) 2.25
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer (2003) 2.24
Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr (2001) 2.21
Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med (1995) 2.20
Discovering carcinogens in the occupational environment: a novel epidemiologic approach. J Natl Cancer Inst (1981) 2.18
Height and glucose tolerance in adult subjects. Diabetologia (1991) 2.17
Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care (1999) 2.16
Analysis of a cluster randomized trial with binary outcome data using a multi-level model. Stat Med (2000) 2.14
Sample size determination for studies of gene-environment interaction. Int J Epidemiol (2001) 2.11
Seasonality in the diagnosis of acute lymphocytic leukaemia. Br J Cancer (1997) 2.09
Meta-analysis of continuous outcome data from individual patients. Stat Med (2001) 2.07
Evaluation of screening programmes for gynaecological cancer. Br J Cancer (1985) 2.06
Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. BMJ (1995) 2.06
A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med (2000) 2.06
Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg (2007) 2.04
Should the frequency of surveillance for small abdominal aortic aneurysms be reduced? Eur J Vasc Endovasc Surg (2013) 2.04
Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst (1985) 2.00
The Lancet's statistical review process: areas for improvement by authors. Lancet (1992) 2.00